News

Vaishali Pharma bags order worth US $270,000 from Afghanistan

This achievement enables the company to strengthen its presence in the high growth market of South Asian countries

  • By IPP Bureau | April 26, 2021

Vaishali Pharma Limited has received an order worth US $270,000 from Afghanistan for the supply of API, packaging material like capsule, glass vial, rubber stopper, flipoff seal, sterile water for injection etc., and speciMic machinery setup such as tablets manufacturing machines.

This remarkable achievement enables the company to strengthen its presence in the high growth market of South Asian countries and entitles the company to reach out to more and more territories.

The pharmaceutical market of Afghanistan has always been dominated by imported drugs and medicines from all around the world. Along with the good quality imported pharmaceuticals a large number of illicit medicines, spurious drugs and smuggled vaccines are circulating in the marketplace. Moreover, the pharmaceutical factories in the country are unable to manufacture high quality medicines to fulfill the healthcare requirements in the whole country. However, still 95% of Afghanistan’s pharmaceutical needs are still being met by imported medicines, most of them imported from India and other European countries.

Upcoming E-conference

Other Related stories

Startup

Digitization

Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
Collaborative models are practical way to build capability in biologics: Manoj Kumar Panicker, Cytiva and Dr. Sanjib Banerjee, Veeda Lifesciences
(L-R) Manoj Kumar Panicker, General Manager, South Asia, Cytiva and Dr. Sanjib Banerjee, Chief Operating Officer (Biopharma Services), Veeda Lifesciences.